Get started
Author

Rodanthi Fioretzaki

Observed names: R. Fioretzaki, Rodanthi G. Fioretzaki
ORCID: 0000-0003-1219-8715
Observed ORCID: 0000-0003-1219-8715
OpenAlex ID: A5036953226
Immunotherapy for Cholangiocarcinoma: a 2021 Update
2021 · Nikolaos Charalampakis, Georgios Papageorgiou, et al. · Immunotherapy · 19
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia
2022 · Anna Montanaro, Samuel Kitara, et al. · Cell Death and Disease · 17
PDF
Immune Checkpoint Inhibitors and Combinations with Other Agents in Cholangiocarcinoma
2023 · Nikolaos Skouteris, Georgios Papageorgiou, et al. · Immunotherapy · 11
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
2022 · Nikolaos Charalampakis, Sergios Tsakatikas, et al. · World Journal of Gastrointestinal Oncology · 10
Annexin A2 in Tumors of the Gastrointestinal Tract, Liver, and Pancreas
2024 · Konstantinos Christofidis, Alexandros Pergaris, et al. · Cancers · 8
Assessment of Synergistic Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Sarcoma
2020 · Aikaterini Mastoraki, Dimitrios Schizas, et al. · Molecular Diagnosis & Therapy · 8
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma
2019 · Giulia Mazzaschi, Paola Bordi, et al. · Clinical Lung Cancer · 8
Progastrin: An Overview of Its Crucial Role in the Tumorigenesis of Gastrointestinal Cancers
2024 · Rodanthi Fioretzaki, Panagiotis Sarantis, et al. · Biomedicines · 6
PDF
The Interplay Between Esophageal Adenocarcinoma and Its Tumor Microenvironment: Toward Innovative Therapies
2025 · Rodanthi Fioretzaki, Eleni-Myrto Trifylli, et al. · Cells · 5
PDF
Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab
2020 · Georgios I. Papageorgiou, Sergios A. Tsakatikas, et al. · Anti-Cancer Drugs · 5
An overview of current results with the vincristine-irinotecan-temozolomide combination with or without bevacizumab in pediatric, adolescence and adult solid tumors
2021 · Sergios Tsakatikas, George Papageorgiou, et al. · Critical Reviews in Oncology/Hematology · 4
CD20 × CD3 Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas: Current Evidence, Therapeutic Integration, and Future Directions
2026 · Polyxeni Giamaiou, Rodanthi Fioretzaki, et al. · Medicina · 3
Venetoclax–Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview
2025 · Maria Dimou, Rodanthi Fioretzaki, et al. · Cancers · 3
PDF
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase
2024 · Bruno Lorusso, Antonella Nogara, et al. · International Journal of Molecular Sciences · 2
PDF
In vitro effects of caffeine on human umbilical artery and vein endothelial cells
2018 · B. Lorusso, R. Vilella, et al. · Vascular Pharmacology · 2
Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation
2014 · Elena Rossetti, Monica Crugnola, et al. · Blood · 1
Progastrin, annexin A2, and tumor-associated macrophages in gastric adenocarcinoma
2026 · Konstantinos Christofidis, Rodanthi Fioretzaki, et al. · Journal of Pathology and Translational Medicine
Progastrin, Annexin A2 and Tumor-Associated Macrophages in Gastric Adenocarcinomas
2025 · Konstantinos Christofidis, Rodanthi Fioretzaki, et al. · medRxiv
PDF
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML
2016 · Federico Quaini, Rodanthi Fioretzaki, et al. · Blood
Works count: 19
Citation count: 112
H-index: 7
I10-index: 4
Year
Topic
Type